Drug Profile
Ethambutol/isoniazid/pyrazinamide/rifampicin
Alternative Names: Isoniazid/pyrazinamide/rifampicin/ethambutol; Myrin- p Forte; Pyrazinamide/rifampicin/ethambutol/isoniazid; Rifampicin/ethambutol/isoniazid/pyrazinamideLatest Information Update: 31 Oct 2021
Price :
$50
*
At a glance
- Originator Pfizer
- Class Antituberculars; Ethylenediamines; Hydrazines; Isonicotinic acids; Pyrazines; Rifamycins
- Mechanism of Action Cell wall inhibitors; DNA-directed RNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Tuberculosis
Most Recent Events
- 06 Sep 2017 No development reported - Phase-I for Tuberculosis in Singapore (PO)
- 12 Aug 2015 Launched for Tuberculosis in Philippines (PO)